U.S. FDA rejects psychedelic drug treatment for PTSD. Here’s why – National
Federal health regulators on Friday declined to approve the psychedelic drug MDMA as a therapy for PTSD, a major setback for groups seeking a breakthrough decision in favor of using mind-altering substances to treat serious mental health conditions. Drugmaker Lykos Therapeutics said the FDA notified the company that its drug “could not be approved based … Read more
